PET Studies with Carbon-11 Radioligands in Neuropsychopharmacological Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|18|1907-1929

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.18, 2001-12, pp. : 1907-1929

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PET and SPECT Imaging of the Opioid System: Receptors, Radioligands and Avenues for Drug Discovery and Development

By  

Current Pharmaceutical Design, Vol. 13, Iss. 1, 2007-01 ,pp. : 33-49

Bentham Science Publishers

Access to resources Recommend Favorite

Selection, design and evaluation of new radioligands for PET studies of cardiac adrenoceptors

By Pike V.W.   Law M.P.   Osman S.   Davenport R.J.   Rimoldi O.   Giardina D.   Camici P.G.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 191-200

Elsevier

Access to resources Recommend Favorite

Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging

By  

Current Medicinal Chemistry, Vol. 23, Iss. 18, 2016-06 ,pp. : 1818-1869

Bentham Science Publishers

Access to resources Recommend Favorite

PET Radioligands for In Vivo Visualization of Neuroinflammation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 37, 2014-11 ,pp. : 5897-5913

Bentham Science Publishers

Access to resources Recommend Favorite

Quantification of SPECT and PET for Drug Development

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 17-21

Bentham Science Publishers

Access to resources Recommend Favorite